Sanofi SA (NYSE: SNY) shares dipped 1% to $40.93, following a report that it was in talks with Medivation Inc. over a sweetened offer. Medivation later confirmed it had received and rejected an offer of $58.00 per share in cash from Sanfoi, plus a CVR for Talazoparib sales, worth up to $3.00 per share. Share volume was 585,000, compared to an all-day average of two million
